Vivo Capital
Vivo Capital

Vivo Capital

Measured by AhrefsDR35 out of 100, Below median. Ahrefs DR. Open the scores section.Ahrefs DR: 35/100. Below median. Measured by Ahrefs. Median 44.

Global healthcare investment firm focused on catalyzing innovation and growth across venture, private equity, and public equity strategies.

1996VC5 portfolio$2.9B AUMPalo Alto, U.S.

About

Vivo Capital is a global healthcare specialist with a multi-strategy investment platform covering venture capital, private equity, and public equity. The firm seeks to support the expansion of healthcare access and catalyze innovation and growth through investments in biopharmaceuticals, specialty pharmaceuticals, medical devices, and other life sciences sectors. They invest in companies with promising development-stage and commercial-stage therapeutic products in the U.S.

Key facts

Website
vivocapital.com
Type
VC
Headquarters
Palo Alto, U.S.
Funds raised
$2.9B
Portfolio companies
5
Stages
Seed
Series A
Series B
Growth
Buyout
Sector focus
Agricultural Chemicals
Drug Discovery
Biotechnology
Pharmaceuticals
Medical Devices

Recent investments

Recent funding rounds Vivo Capital took part in
DateCompanyRoundAmount
20 Mar 2026EarendilFunding Round$787M

Test your Ahrefs DR

The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.

Write the first review

Frequently asked

What companies has Vivo Capital invested in?

Vivo Capital has invested in Earendil, ProNAi Therapeutics, Earendil Labs, VISEN Pharmaceuticals, Klavi and 1 more.

Founders (2)
FK
Frank Kung
Co-Founder, Managing Partner
EG
Edgar G. Engleman
Co-Founder, Managing Partner

Find a founder email

SEC filings, insider activity, nonprofit links and pay benchmarks for Vivo Capital: